Perform Another (Advanced) Search

1.  CenterWatch: Clinical Trials in Category (679) Post-Menopausal Osteoporosis
...A Study of Boniva (Ibandronate) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia Birmingham : Research Site: A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal ...
...A Study of Boniva (Ibandronate) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia Huntsville : Research Site: A Study of Bonviva (Ibandronate) in Patients With Post-Menopausal Osteoporosis Mobile ...
View Page

2.  CenterWatch: Clinical Trials in Category (814) Post-Menopausal Osteopenia
...CenterWatch: Clinical Trials in Category (814) Post-Menopausal Osteopenia Post-Menopausal Osteopenia State • Colorado • Maryland • Michigan • Missouri • Nebraska • New Mexico • Ohio • Oregon • Virginia Country • [X]   France Colorado ...
View Page

3. Clinical Trial Results: Post-Menopausal Osteopenia
...Clinical Trial Results: Post-Menopausal Osteopenia Clinical Trial Results: Post-Menopausal Osteopenia Product Name: Bonviva/Boniva [ibandronate] Date of Report: To be Published Phase: III A Study ...
View Page

4.  Study Posting (4519) Trial #126401, Post-Menopausal Osteopenia, Richmond, VA
...Study Posting (4519) Trial #126401, Post-Menopausal Osteopenia, Richmond, VA Trial Information A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia Status: Completed Protocol Number: BA18492 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title ...
View Page

5.  Study Posting (4519) Trial #126448, Post-Menopausal Osteopenia, Norfolk , VA
...Study Posting (4519) Trial #126448, Post-Menopausal Osteopenia, Norfolk , VA Trial Information A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia Status: Completed Protocol Number: BA18492 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title ...
View Page

6.  Study Posting (4519) Trial #126400, Post-Menopausal Osteopenia, Portland, OR
...Study Posting (4519) Trial #126400, Post-Menopausal Osteopenia, Portland, OR Trial Information A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia Status: Completed Protocol Number: BA18492 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title ...
View Page

7.  Study Posting (4519) Trial #126467, Post-Menopausal Osteopenia, Cincinnati, OH
...Study Posting (4519) Trial #126467, Post-Menopausal Osteopenia, Cincinnati, OH Trial Information A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia Status: Completed Protocol Number: BA18492 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title ...
View Page

8.  Study Posting (4519) Trial #126395, Post-Menopausal Osteopenia, Albuquerque, NM
...Study Posting (4519) Trial #126395, Post-Menopausal Osteopenia, Albuquerque, NM Trial Information A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia Status: Completed Protocol Number: BA18492 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title ...
View Page

9.  Study Posting (4519) Trial #126399, Post-Menopausal Osteopenia, Omaha, NE
...Study Posting (4519) Trial #126399, Post-Menopausal Osteopenia, Omaha, NE Trial Information A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia Status: Completed Protocol Number: BA18492 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title ...
View Page

10.  Study Posting (4519) Trial #126521, Post-Menopausal Osteopenia, St Louis, MO
...Study Posting (4519) Trial #126521, Post-Menopausal Osteopenia, St Louis, MO Trial Information A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia Status: Completed Protocol Number: BA18492 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title ...
View Page

11.  Study Posting (4519) Trial #126434, Post-Menopausal Osteopenia, Detroit, MI
...Study Posting (4519) Trial #126434, Post-Menopausal Osteopenia, Detroit, MI Trial Information A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia Status: Completed Protocol Number: BA18492 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title ...
View Page

12.  Study Posting (4519) Trial #126397, Post-Menopausal Osteopenia, Bethesda, MD
...Study Posting (4519) Trial #126397, Post-Menopausal Osteopenia, Bethesda, MD Trial Information A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia Status: Completed Protocol Number: BA18492 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title ...
View Page

13.  Study Posting (4519) Trial #126398, Post-Menopausal Osteopenia, Lakewood, CO
...Study Posting (4519) Trial #126398, Post-Menopausal Osteopenia, Lakewood, CO Trial Information A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia Status: Completed Protocol Number: BA18492 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title ...
View Page

14.  Study Posting (4519) Trial #126410, Post-Menopausal Osteopenia, Toulouse, France
...Study Posting (4519) Trial #126410, Post-Menopausal Osteopenia, Toulouse, France Trial Information A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia. Status: No longer recruiting Protocol Number: ML19357 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official ...
View Page

15.  Study Posting (4519) Trial #126407, Post-Menopausal Osteopenia, Paris, France
...Study Posting (4519) Trial #126407, Post-Menopausal Osteopenia, Paris, France Trial Information A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia. Status: No longer recruiting Protocol Number: ML19357 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official ...
View Page

16.  Study Posting (4519) Trial #126385, Post-Menopausal Osteopenia, Lyon, France
...Study Posting (4519) Trial #126385, Post-Menopausal Osteopenia, Lyon, France Trial Information A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia. Status: No longer recruiting Protocol Number: ML19357 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official ...
View Page

17.  Study Posting (4519) Trial #156429, Post-Menopausal Osteopenia, Saint-Priest En Jarez, France
...Study Posting (4519) Trial #156429, Post-Menopausal Osteopenia, Saint-Priest En Jarez, France Trial Information A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia. Status: No longer recruiting Protocol Number: ML19357 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official ...
View Page

18. Clinical Trial Results by Drug Names
...Title of Study: A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia. Fast Facts: Protocol number: ML19357 Sponsor: Roche SAS Company division: Pharmaceutical Product name: Bonviva/Boniva Generic name: ibandronate Phase of development: III Therapeutic area, approved indication: Post-Menopausal Osteopenia Date of report: To be Published Clinical study summary: This trial does not yet have ...
View Page

19.  Study Posting (4519) Trial #122737, Post-Menopausal Osteoporosis, Madison, WI
...Trial Information PRIOR Study - A Study of Boniva (Ibandronate) in Postmenopausal Women With Osteoporosis or Osteopenia Status: Completed Protocol Number: ML18058 Sponsor: Roche Laboratories Inc. Company Division: Pharmaceutical Official Scientific Title ...
...to evaluate treatment adherence to different regimens of Bonviva in postmenopausal women with osteoporosis or osteopenia who are intolerant to daily or weekly alendronate or risedronate therapy due to gastrointestinal (GI ...
View Page

20.  Study Posting (4519) Trial #125125, Post-Menopausal Osteoporosis, Tacoma, WA
...Trial Information PRIOR Study - A Study of Boniva (Ibandronate) in Postmenopausal Women With Osteoporosis or Osteopenia Status: Completed Protocol Number: ML18058 Sponsor: Roche Laboratories Inc. Company Division: Pharmaceutical Official Scientific Title ...
...to evaluate treatment adherence to different regimens of Bonviva in postmenopausal women with osteoporosis or osteopenia who are intolerant to daily or weekly alendronate or risedronate therapy due to gastrointestinal (GI ...
View Page